62 results found (page 5 of 5)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635035

…second primary HNSCC with prior RT Radiation + Nivolumab 20 (estimated) Adverse Events Oslo University Hospital Bristol-Myers Squibb Recruiting NCT03546582 2 Recurrent or new second primary HNSCC SBRT + Pembrolizumab SBRT 102 (estimated) PFS RTOG Foundation Merck Sharp & Dohme Co…